Giulia Masiero MD , Anna Franzone MD, PhD , Valeria Paradies MD , Nicole Karam MD, PhD , Chiara Fraccaro MD, PhD , Chiara De Biase MD , Mirvat Alasnag MD , Giulia Botti MD , Angelicarosa Cascone MD , Ana Belen Cid-Alvarez MD, PhD , Tanja K. Rudolph MD, PhD , Marta Kaluzna-Oleksy MD, PhD , Stephane Manzo-Silberman MD, PhD , Julinda Mehilli MD, PhD , Barbara E. Stähli MD, PhD , Julia Grapsa MD, PhD , Kyriakos Panaou MD , Barbara Bellini MD , Joanna J. Wykrzykowska MD, PhD , Sabine Bleiziffer MD, PhD , Alaide Chieffo MD, PhD
{"title":"Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women","authors":"Giulia Masiero MD , Anna Franzone MD, PhD , Valeria Paradies MD , Nicole Karam MD, PhD , Chiara Fraccaro MD, PhD , Chiara De Biase MD , Mirvat Alasnag MD , Giulia Botti MD , Angelicarosa Cascone MD , Ana Belen Cid-Alvarez MD, PhD , Tanja K. Rudolph MD, PhD , Marta Kaluzna-Oleksy MD, PhD , Stephane Manzo-Silberman MD, PhD , Julinda Mehilli MD, PhD , Barbara E. Stähli MD, PhD , Julia Grapsa MD, PhD , Kyriakos Panaou MD , Barbara Bellini MD , Joanna J. Wykrzykowska MD, PhD , Sabine Bleiziffer MD, PhD , Alaide Chieffo MD, PhD","doi":"10.1016/j.shj.2025.100666","DOIUrl":null,"url":null,"abstract":"<div><div>The impact of sex on the baseline characteristics, morphology, and clinical presentation of degenerative aortic stenosis (AS) is well-documented but remains poorly understood. Unlike valve surgery, for which patients have been predominantly male, percutaneous treatment of AS has shown balanced representation of both sexes, with women demonstrating greater benefit from transfemoral aortic valve replacement compared to surgical treatment. This review explores sex-specific differences in the epidemiology, pathophysiology, diagnostic challenges, treatment approaches, and clinical outcomes of degenerative AS. Furthermore, it addresses technical, sex-specific considerations in transfemoral aortic valve replacement, including preprocedural screening, device selection, implantation strategy, and postprocedural management.</div></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"9 7","pages":"Article 100666"},"PeriodicalIF":2.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Structural Heart","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2474870625002581","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
The impact of sex on the baseline characteristics, morphology, and clinical presentation of degenerative aortic stenosis (AS) is well-documented but remains poorly understood. Unlike valve surgery, for which patients have been predominantly male, percutaneous treatment of AS has shown balanced representation of both sexes, with women demonstrating greater benefit from transfemoral aortic valve replacement compared to surgical treatment. This review explores sex-specific differences in the epidemiology, pathophysiology, diagnostic challenges, treatment approaches, and clinical outcomes of degenerative AS. Furthermore, it addresses technical, sex-specific considerations in transfemoral aortic valve replacement, including preprocedural screening, device selection, implantation strategy, and postprocedural management.